<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-106337</identifier>
<setSpec>0214-9168</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Apolipoprotein-B100 concentrations are associated with increased arterial stiffness in familial hypercholesterolemia</dc:title>
<dc:description xml:lang="en">Introduction: Familial hypercholesterolemia (FH) is a genetic disease of lipoprotein metabolism conferring a high cardiovascular risk (CVR) to patients. Arterial wall properties and function study are of interest in FH subjects. Arterial stiffness is associated with a higher CVR. The aim of our study was to determine the arterial stiffness in FH patients and its association with vascular and biochemical parameters. Methods: One hundred and twenty-&amp;#64257;ve FH subjects and 59 healthy volunteers were included. Clinical, anthropometrical and biochemical data were collected. Vascular studies were performed by measuring the augmentation index adjusted for 75 beats per minute of heart rate(AIx@75) as an arterial stiffness marker by peripheral artery tonometry, the carotid intimamedia thickness (cIMT) by ultrasonography and the brachial-ankle index (ABI).Results: FH patients showed a signi&amp;#64257;cant increase in the AIx@75 respect to control group (CG)(9,8 ¡À 18,3 vs 2,4 ¡À 111,1%; p = 0,001), and higher cIMT (0,758 ¡À 0,280 vs 0,635 ¡À 0,160 mm;p &lt; 0,001). We did not observe differences in ABI between groups. The AIx@75 values were directly correlated with LDL cholesterol, Apolipoprotein-B100 (Apo-B 100), triglycerides and sE-selectin. Apo-B100, systolic blood pressure and fasting glucose were the main determinants of the AIx@75. AIx@75 was also an independent predictor of cIMT. Conclusions: FH patients have increased arterial stiffness. The AIx@75 is clearly associated withApo-B100 concentrations and it is a cIMT determinant. The AIx@75 may be an early marker of CVR in FH subjects (AU)</dc:description>
<dc:creator>Heras, Mercedes</dc:creator>
<dc:creator>Masana, Lluis</dc:creator>
<dc:creator>Ibarretxe, Daiana</dc:creator>
<dc:creator>Ferre, Raimon</dc:creator>
<dc:creator>Merino, Jordi</dc:creator>
<dc:creator>Plana, Nuria</dc:creator>
<dc:creator>Girona, Josefa</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción: La hipercolesterolemia familiar (HF) heterocigota es un trastorno genético del metabolismo de las lipoproteinas que conlleva un riesgo cardiovascular (RCV) muy elevado. El estudio de la pared arterial y su función son de especial interés en pacientes con HF. La rigidez arterial está  asociada a un incremento del RCV. El objetivo del estudio fue determinar la rigidez arterial en pacientes con HF y su asociación con par¨¢metros bioquímicos y vasculares. Métodos (..)  (AU)</dc:description>
<dc:source>Clín. investig. arterioscler. (Ed. impr.);24(6): 289-296, nov.-dic. 2012. ilus, tab</dc:source>
<dc:identifier>ibc-106337</dc:identifier>
<dc:title xml:lang="es">Las concentraciones de Apo-B100 en los pacientes con hipercolesterolemia familiar se asocian a una mayor rigidez arterial</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d52261^s22002</dc:subject>
<dc:subject>^d54813</dc:subject>
<dc:subject>^d23568^s22002</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d54672^s22074</dc:subject>
<dc:subject>^d7118^s22032</dc:subject>
<dc:type>article</dc:type>
<dc:date>201212</dc:date>
</metadata>
</record>
</ibecs-document>
